BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14462629)

  • 21. Theophylline-induced increase in plasma uric acid--purine catabolism increased by theophylline.
    Yamamoto T; Moriwaki Y; Suda M; Takahashi S; Hiroishi K; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):257-61. PubMed ID: 1889911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion kinetics of urea, creatinine and uric acid in blood during hemodialysis. Clinical implications.
    Descombes E; Perriard F; Fellay G
    Clin Nephrol; 1993 Nov; 40(5):286-95. PubMed ID: 8281718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Uric acid analysis in thalassemia trait carriers].
    Gallerani M; Faggioli M; Martinelli L; Ricci A; Coletti M
    Minerva Med; 1989 Nov; 80(11):1199-204. PubMed ID: 2601872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ethanol on uric acid level].
    Yamamoto T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():143-7. PubMed ID: 12629708
    [No Abstract]   [Full Text] [Related]  

  • 25. Normal urate transport into erythrocytes in familial renal hypouricemia and in the Dalmatian dog.
    Vinay P; Gattereau A; Moulin B; Gougoux A; Lemieux G
    Can Med Assoc J; 1983 Mar; 128(5):545-9. PubMed ID: 6825020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of serum uric acid increase during continuous xylitol infusions].
    Kaiser W; Stocker K; Heuckenkamp PU
    Infusionstherapie (1973); 1974 Oct; 1(7):548-50. PubMed ID: 4219390
    [No Abstract]   [Full Text] [Related]  

  • 27. Allantoin as a marker of oxidative stress in human erythrocytes.
    Kand'ár R; Záková P
    Clin Chem Lab Med; 2008; 46(9):1270-4. PubMed ID: 18636793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antioxidant capacity of erythrocyte concentrates is increased during the first week of storage and correlated with the uric acid level.
    Bardyn M; Maye S; Lesch A; Delobel J; Tissot JD; Cortés-Salazar F; Tacchini P; Lion N; Girault HH; Prudent M
    Vox Sang; 2017 Oct; 112(7):638-647. PubMed ID: 28833258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The genesis of hyperuricemia in patients with essential hypertension (author's transl)].
    Wessels F; Heinze A; Oberwittler W; Losse H
    Med Klin; 1974 Apr; 69(14):599-606. PubMed ID: 4365815
    [No Abstract]   [Full Text] [Related]  

  • 30. Exercise induced alteration of erythrocyte glycolysis associated with myogenic hyperuricemia.
    Shimizu T; Kono N; Kiyokawa H; Yamada Y; Hara N; Mineo I; Kawachi M; Nakajima H; Wang YL; Kuwajima M
    Adv Exp Med Biol; 1989; 253A():375-9. PubMed ID: 2624216
    [No Abstract]   [Full Text] [Related]  

  • 31. [Erythrocyte uric acid in the non-gouty subject].
    Asch L; Schirardin H; Weryha A
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):731-2. PubMed ID: 7455606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical aspects and studies of erythrocyte metabolism during poisoning with sodium chlorate].
    Mengele K; Schwarzmeier J; Schmidt P; Moser K
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):120-5. PubMed ID: 5800711
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship between uric acid and potassium in normal subjects.
    Kennedy AC; Boddy K; King PC; Brennan J; Anderson JA; Buchanan WW
    Ann Rheum Dis; 1978 Aug; 37(4):333-8. PubMed ID: 686865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of phototherapy on serum uric acid (author's transl)].
    Böhles H; Schnall B
    Klin Padiatr; 1981 Jul; 193(4):308-10. PubMed ID: 7265799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of phenylbutazone on uric acid in plasma and erythrocytes; relation to clinical phenomena].
    LEVY M; SICHERE RM
    Rev Rhum Mal Osteoartic; 1955 Mar; 22(3):225-33. PubMed ID: 14396123
    [No Abstract]   [Full Text] [Related]  

  • 36. The transport and excretion of uric acid in man; true uric acid in normal cerebrospinal fluid, in plasma, and in ultrafiltrates of plasma.
    WOLFSON WQ; LEVINE R; TINSLEY M
    J Clin Invest; 1947 Sep; 26(5):991-4. PubMed ID: 20264987
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of 5-phosphoribosyl-1-pyrophosphate (PRPP) in erythrocytes, leukocytes and lymphocytes of normal and gouty subjects].
    Pompucci G; Micheli V; Marcolongo R
    Reumatismo; 1975; 27(1):228-34. PubMed ID: 1233637
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contributions on the mechanism of phosphate transport in human erythrocytes].
    SCHAUER R; HILLMANN G
    Hoppe Seylers Z Physiol Chem; 1961 Jun; 325():9-34. PubMed ID: 13747316
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome.
    Nishida Y; Akaoka I; Nishizawa T; Maruki M; Maruki K
    Ann Rheum Dis; 1977 Jun; 36(3):261-3. PubMed ID: 141914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The purine revolution.
    Lesch M
    N Engl J Med; 1970 Nov; 283(22):1221-2. PubMed ID: 4319627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.